{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:11:49Z","timestamp":1790748709235,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.saa.2019.117841","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:17:03Z","timestamp":1574338623000},"page":"117841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Conventional and first derivative synchronous spectrofluorimetric methods for the simultaneous determination of cisatracurium and nalbuphine in biological fluids"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1806-6465","authenticated-orcid":false,"given":"Mona E.","family":"El Sharkasy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Walash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-6504","authenticated-orcid":false,"given":"M.M.","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2019.117841_bb0005","series-title":"Lippincott Illustrated Reviews Pharmacology","author":"Whalen","year":"2015"},{"key":"10.1016\/j.saa.2019.117841_bb0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0039-9140(99)00084-3","article-title":"Spectrofluorimetric determination of cisatracurium and mivacurium in spiked human serum and pharmaceuticals","volume":"49","author":"Fern\u00e1ndez","year":"1999","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2019.117841_bb0015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0039-9140(00)00604-4","article-title":"Electrochemical oxidation of cisatracurium on carbon paste electrode and its analytical applications","volume":"53","author":"Torres","year":"2001","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2019.117841_bb0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0731-7085(97)00262-8","article-title":"HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products1","volume":"16","author":"Zhang","year":"1998","journal-title":"Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2019.117841_bb0025","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1080\/10826079708005563","article-title":"High performance liquid chromatographic assay for cisatracurium and its metabolites in human urine","volume":"20","author":"Bryant","year":"1997","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.saa.2019.117841_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jchromb.2014.02.023","article-title":"High-performance liquid chromatography assay with programmed flow elution for cisatracurium in human plasma: application to pharmacokinetics in infants and children","volume":"955","author":"Gao","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2019.117841_bb0035","first-page":"713","article-title":"Determination of cisatracurium in human plasma by iron-pair HPLC with fluorescence detection","volume":"31","author":"LI","year":"2011","journal-title":"Chin. J. Pharm. Anal."},{"key":"10.1016\/j.saa.2019.117841_bb0040","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chroma.2009.12.025","article-title":"Determination of atracurium, cisatracurium and mivacurium with their impurities in pharmaceutical preparations by liquid chromatography with charged aerosol detection","volume":"1217","author":"B\u0142a\u017cewicz","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.saa.2019.117841_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/chromsci\/bmy027","article-title":"Simultaneous HPLC determination of Cisatracurium and Propofol in human plasma via Fluorometric detection","volume":"56","author":"Ayad","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2019.117841_bb0050","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/jssc.201500092","article-title":"Capillary electrophoresis with electrochemiluminescence detection for the simultaneous determination of cisatracurium besylate and its degradation products in pharmaceutical preparations","volume":"38","author":"Zuo","year":"2015","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.saa.2019.117841_bb0055","series-title":"Martindale, the Complete Drug Reference","author":"Sweetman","year":"2011"},{"key":"10.1016\/j.saa.2019.117841_bb0060","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.4067\/S0717-97072013000300025","article-title":"Kinetic spectrophotometry method for the determination of morphine, nalbuphine and naltrexone drugs in bulk and pharmaceutical formulations","volume":"58","author":"El-Didamony","year":"2013","journal-title":"J. Chil. Chem. Soc."},{"key":"10.1016\/j.saa.2019.117841_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/MGC-140132","article-title":"Determination of tramadol, morphine, nalbuphine and naltrexone analgesic drugs using potassium permanganate by visible spectrophotometry","volume":"13","author":"El-Didamony","year":"2014","journal-title":"Main Group Chem"},{"key":"10.1016\/j.saa.2019.117841_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/bio.2428","article-title":"New spectrofluorimetric and spectrophotometric methods for the determination of the analgesic drug, nalbuphine in pharmaceutical and biological fluids","volume":"28","author":"El-Didamony","year":"2013","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2019.117841_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.saa.2018.02.048","article-title":"New spectrophotometric\/chemometric assisted methods for the simultaneous determination of imatinib, gemifloxacin, nalbuphine and naproxen in pharmaceutical formulations and human urine","volume":"198","author":"Belal","year":"2018","journal-title":"Spectrochim. Acta, Part A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2019.117841_bb0080","first-page":"1253","article-title":"Stability-indicating spectrofluorimetric determination of nalbuphine hydrochloride in raw material and pharmaceutical preparation","volume":"5","author":"Attia","year":"2014","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.saa.2019.117841_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.snb.2016.02.094","article-title":"A new sensor for determination of nalbuphine using NiO\/functional single walled carbon nanotubes nanocomposite and ionic liquid","volume":"230","author":"Fouladgar","year":"2016","journal-title":"Sens. Actuators, B: Chem."},{"key":"10.1016\/j.saa.2019.117841_bb0090","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/bmc.1601","article-title":"Validated LC-MS\/MS assay for the quantitative determination of nalbuphine in human plasma and its application to a pharmacokinetic study","volume":"25","author":"Cai","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.saa.2019.117841_bb0095","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/bmc.2867","article-title":"Simultaneous determination of nalbuphine and its prodrug sebacoly dinalbuphine ester in human plasma by ultra-performance liquid chromatography\u2013tandem mass spectrometry and its application to pharmacokinetic study in humans","volume":"27","author":"Huang","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.saa.2019.117841_bb0100","first-page":"15","article-title":"Stability-indicating HPLC method for determination of Nalbuphine hydrochloride","volume":"1","author":"Attia","year":"2014","journal-title":"Int. J. Res. Pharm. Biomed. Sci."},{"key":"10.1016\/j.saa.2019.117841_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1365\/s10337-003-0146-z","article-title":"Simultaneous determination of nalbuphine and opiates in human hair by gas chromatography-mass spectrometry","volume":"59","author":"Kim","year":"2004","journal-title":"Chromatographia"},{"key":"10.1016\/j.saa.2019.117841_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5603\/AIT.2015.0036","article-title":"The use of nalbuphine in paediatric anaesthesia","volume":"47","author":"Kubica-Cieli\u0144ska","year":"2015","journal-title":"Anaesthesiol. intensive Ther."},{"key":"10.1016\/j.saa.2019.117841_bb0115","series-title":"Reviews in Fluorescence 2010","first-page":"95","article-title":"Synchronous fluorescence spectroscopy and its applications in clinical analysis and food safety evaluation","author":"Li","year":"2012"},{"key":"10.1016\/j.saa.2019.117841_bb0120","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Step","article-title":"ICH harmonised tripartite guidelines. Validation of analytical procedures: Methodology Q2","author":"I.S. Committee","year":"1996"},{"key":"10.1016\/j.saa.2019.117841_bb0125","doi-asserted-by":"crossref","unstructured":"J. Miller and, J.C. Miller, Statistics and Chemometrics for Analytical Chemistry, in, Pearson Education, 2005.","DOI":"10.1002\/9780470988459.ch8"},{"key":"10.1016\/j.saa.2019.117841_bb0130","series-title":"Clarke\u2019s Analysis of Drugs and Poisons","author":"Moffat","year":"2011"},{"key":"10.1016\/j.saa.2019.117841_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10895-013-1273-z","article-title":"Micelle-enhanced Spectrofluorimetric method for determination of Cyproheptadine hydrochloride in tablets: application to In-vitro drug release and content uniformity test","volume":"24","author":"Belal","year":"2014","journal-title":"J. Fluorescence"},{"key":"10.1016\/j.saa.2019.117841_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/php.12860","article-title":"Database of absorption and fluorescence spectra of> 300 common compounds for use in Photochem CAD","volume":"94","author":"Taniguchi","year":"2018","journal-title":"Photochem. Photobiol."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519312314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519312314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:14:55Z","timestamp":1761354895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142519312314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"alternative-id":["S1386142519312314"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2019.117841","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conventional and first derivative synchronous spectrofluorimetric methods for the simultaneous determination of cisatracurium and nalbuphine in biological fluids","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2019.117841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117841"}}